News - Latest

102 news items

Enter search criteria

Fill in keyword(s) to narrow your search.

Period

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

Subscribe to latest news

MEB Citrix systems switched off

Out of precaution the MEB Citrix systems have been switched off, due to the recent Citrix safety warnings. As a result, MEB ...

News item | 19-01-2020 | 20:00

Shorter timetable for procedure for changing parallel package leaflet

The Medicines Evaluation Board (MEB) has decided to implement a shorter timetable for the procedure for changing the parallel ...

News item | 30-12-2019 | 08:38

MEB fee rate change as of January 2020

The Medicines Evaluation Board (MEB) is increasing the fee rates for authorisation applications, authorisation changes and the ...

News item | 24-12-2019 | 12:00

Regulatory Science Magazine 9: opioids and Real World Data

Today the Medicines Evaluation Board (MEB) publishes the 9th edition of its Regulatory Science Magazine. This edition features ...

News item | 12-12-2019 | 13:30

Change for consultation procedures resulting from the implementation of Medical Device Regulation (MDR)

As of 26 May 2020 the Medicines Evaluation Board (MEB) will provide advice under the new Medical Device Regulation (MDR, EU ...

News item | 21-11-2019 | 13:30

Changes to product information must be made more quickly

Within Europe agreements are regularly made regarding changes to information on medicinal products. In many cases it takes too ...

News item | 14-10-2019 | 14:00

Year-end withdrawals medicines for human use

Withdrawal requests for (parallel) marketing authorisations per 31 December, the so-called 'year-end withdrawals' for medicines ...

News item | 17-09-2019 | 09:00

8th edition Regulatory Science Magazine

Today the Medicine Evaluation Board (MEB) publishes the 8th edition of its Regulatory Science Magazine. This edition focuses on ...

News item | 04-06-2019 | 18:30

MEB and ZIN start pilot to accelerate access to innovative medicines

Accelerating patient access to reimbursable innovative medicines has been on the wish list of the government, patient ...

News item | 09-05-2019 | 08:00

Amended policy relating to patented indications

The Medicines Evaluation Board (MEB) will no longer publish the full product information about the active substance of generic ...

News item | 08-05-2019 | 13:00